Danish retailers sign Bangladesh safety reform plan
COPENHAGEN (Reuters) - PWT Group, a user of the clothing factory that collapsed in Bangladesh in April, and five other Danish firms, have agreed to sign an international accord on...
Home > Reviews
All Stories
U.S. rejection of Novo drug seen temporary but costly
COPENHAGEN (Reuters) - U.S. regulators are likely to approve Novo Nordisk's long-acting insulin drug in three years after a surprise rejection earlier this month, analysts forecast in a poll. The...
U.S. rejection of Novo drug seen temporary but costly
COPENHAGEN (Reuters) - U.S. regulators are likely to approve Novo Nordisk's long-acting insulin drug in three years after a surprise rejection earlier this month, analysts forecast in a poll. The...
Novo raises targets on Victoza, insulin demand
COPENHAGEN (Reuters) - Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations, sending its...
Novo raises targets on Victoza, insulin demand
COPENHAGEN (Reuters) - Denmark's Novo Nordisk hiked its full-year sales and profit targets after rising demand for diabetes drug Victoza and insulins helped the company beat second-quarter expectations, sending its...